{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:49:11Z","timestamp":1785149351115,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Hepatitis C virus infection is a major health problem in hemodialysis patients. Occult HCV infection is defined as the presence of HCV-RNA in hepatocytes or peripheral blood mononuclear cells without the detection of HCV-RNA in the serum. We aimed to evaluate the prevalence and predictors of occult HCV infection among hemodialysis patients after treatment with direct-acting antiviral agents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This research is a cross-sectional study that included 60 HCV patients maintained on regular HD patients who achieved 24\u00a0weeks of sustained virological response after treatment with direct-acting antiviral agents. Real-time PCR was performed to detect HCV-RNA in peripheral blood mononuclear cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HCV-RNA was detected in peripheral blood mononuclear cells of three patients (5%). Occult HCV infection cases were treated by Interferon\/ribavirin before direct-acting antiviral agents and two of them had raised pre-treatment alanine aminotransferase levels. Logistic regression analyses revealed that high pre-treatment viral load and raised pre-treatment alanine aminotransferase were associated with an increased risk of occult HCV infection with  <jats:italic>p<\/jats:italic> value of 0.041 and 0.029, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Occult HCV infection in hemodialysis patients who achieved sustained virological response after treatment with direct-acting antiviral agents may occur, and this may necessitate dual testing for HCV in both serum and peripheral blood mononuclear cells to ensure viral clearance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trials registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT04719338.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11255-023-03621-1","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T09:02:25Z","timestamp":1684573345000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Occult hepatitis C virus infection in hemodialysis patients who achieved a sustained virological response to directly acting antiviral drugs: is it a concern?"],"prefix":"10.1007","volume":"56","clinical-trial-number":[{"clinical-trial-number":"nct04719338","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hend","family":"Naguib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shady Fouad","family":"Abouelnaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7656-7116","authenticated-orcid":false,"given":"Mohamed Mamdouh","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"26","key":"3621_CR1","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.4254\/wjh.v7.i26.2676","volume":"7","author":"AA Mohamed","year":"2015","unstructured":"Mohamed AA, Elbedewy TA, El-Serafy M, El-Toukhy N, Ahmed W, El Din ZA (2015) Hepatitis C virus: a global view. World J Hepatol 7(26):2676. https:\/\/doi.org\/10.4254\/wjh.v7.i26.2676","journal-title":"World J Hepatol"},{"issue":"10207","key":"3621_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman CW, Dusheiko GM, Hellard M, Sonderup M (2019) Hepatitis C. Lancet 394(10207):1451\u20131466. https:\/\/doi.org\/10.1016\/S0140-6736(19)32320-7","journal-title":"Lancet"},{"key":"3621_CR3","unstructured":"Organization WH (2016) Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization"},{"key":"3621_CR4","doi-asserted-by":"publisher","unstructured":"Mohamed AA, El-Toukhy NE-TR, Said EM, Gabal HM, AbdelAziz H, Doss W et al (2020) Hepatitis C virus: efficacy of new DAAs regimens. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders) 20(2):143\u2013149. https:\/\/doi.org\/10.2174\/1871526519666190121114003","DOI":"10.2174\/1871526519666190121114003"},{"issue":"2","key":"3621_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4254\/wjh.v13.i2.242","volume":"13","author":"MR Hedayati-Moghaddam","year":"2021","unstructured":"Hedayati-Moghaddam MR, Soltanian H, Ahmadi-Ghezeldasht S (2021) Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries: a systematic review and meta-analysis. World J Hepatol 13(2):242\u2013260. https:\/\/doi.org\/10.4254\/wjh.v13.i2.242","journal-title":"World J Hepatol"},{"key":"3621_CR6","doi-asserted-by":"publisher","first-page":"579147","DOI":"10.1155\/2015\/579147","volume":"2015","author":"BM Attar","year":"2015","unstructured":"Attar BM, Van Thiel D (2015) A new twist to a chronic HCV infection: occult hepatitis C. Gastroenterol Res Pract 2015:579147. https:\/\/doi.org\/10.1155\/2015\/579147","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"3621_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.12865\/CHSJ.44.02.02","volume":"44","author":"DC Caragea","year":"2018","unstructured":"Caragea DC, Mihailovici AR, Streba CT, Schenker M, Ungureanu B, Caragea IN et al (2018) Hepatitis C infection in hemodialysis patients. Curr Health Sci J 44(2):107\u2013112. https:\/\/doi.org\/10.12865\/CHSJ.44.02.02","journal-title":"Curr Health Sci J"},{"issue":"6","key":"3621_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4254\/wjh.v7.i6.885","volume":"7","author":"D Ozer Etik","year":"2015","unstructured":"Ozer Etik D, Ocal S, Boyacioglu AS (2015) Hepatitis C infection in hemodialysis patients: a review. World J Hepatol 7(6):885\u2013895. https:\/\/doi.org\/10.4254\/wjh.v7.i6.885","journal-title":"World J Hepatol"},{"issue":"1","key":"3621_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43162-020-00005-0","volume":"32","author":"KMN Kerollos","year":"2020","unstructured":"Kerollos KMN, El-Ameen HA, El Wahed LA, Azoz NMA (2020) Prevalence and seroconversion of hepatitis C among hemodialysis patients in Assiut governorate, Egypt. Egypt J Intern Med 32(1):1\u20136. https:\/\/doi.org\/10.1186\/s43162-020-00005-0","journal-title":"Egypt J Intern Med"},{"key":"3621_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-8-438","volume":"8","author":"S Khan","year":"2011","unstructured":"Khan S, Attaullah S, Ali I, Ayaz S, Khan SN, Siraj S et al (2011) Rising burden of Hepatitis C Virus in hemodialysis patients. Virol J 8:1\u20135. https:\/\/doi.org\/10.1186\/1743-422X-8-438","journal-title":"Virol J"},{"issue":"4","key":"3621_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.5604\/01.3001.0010.0277","volume":"16","author":"R Naghdi","year":"2017","unstructured":"Naghdi R, Ranjbar M, Bokharaei-Salim F, Keyvani H, Savaj S, Ossareh S et al (2017) Occult hepatitis C infection among hemodialysis patients: a prevalence study. Ann Hepatol 16(4):510\u2013513. https:\/\/doi.org\/10.5604\/01.3001.0010.0277","journal-title":"Ann Hepatol"},{"issue":"3","key":"3621_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajg.2018.09.001","volume":"19","author":"NK Ali","year":"2018","unstructured":"Ali NK, Mohamed RR, Saleh BE, Alkady MM, Farag ES (2018) Occult hepatitis C virus infection among haemodialysis patients. Arab J Gastroenterol 19(3):101\u2013105. https:\/\/doi.org\/10.1016\/j.ajg.2018.09.001","journal-title":"Arab J Gastroenterol"},{"key":"3621_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/IDR.S181638","volume":"12","author":"MA Mekky","year":"2019","unstructured":"Mekky MA, Sayed HI, Abdelmalek MO, Saleh MA, Osman OA, Osman HA et al (2019) Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir\/daclatasvir therapy: a multi-center study. Infect Drug Resist 12:273\u2013279. https:\/\/doi.org\/10.2147\/IDR.S181638","journal-title":"Infect Drug Resist"},{"issue":"3","key":"3621_CR14","first-page":"237","volume":"26","author":"MM Yousif","year":"2018","unstructured":"Yousif MM, Elsadek Fakhr A, Morad EA, Kelani H, Hamed EF, Elsadek HM et al (2018) Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents. Infez Med 26(3):237\u2013243","journal-title":"Infez Med"},{"issue":"6","key":"3621_CR15","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1007\/s11356-017-0897-y","volume":"25","author":"G Abdelmoemen","year":"2018","unstructured":"Abdelmoemen G, Khodeir SA, Abou-Saif S, Kobtan A, Abd-Elsalam S (2018) Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study. Environ Sci Pollut Res Int 25(6):5459\u20135464. https:\/\/doi.org\/10.1007\/s11356-017-0897-y","journal-title":"Environ Sci Pollut Res Int"},{"issue":"1","key":"3621_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/JCTH.2016.00054","volume":"5","author":"MDA Abd Alla","year":"2017","unstructured":"Abd Alla MDA, El Awady MK (2017) Hepatitis C virus RNA strands detection in peripheral blood mononuclear cells legitimizes virus eradication in negative serum PCR Na\u00efve and post-treatment patients. J Clin Transl Hepatol 5(1):1\u20138. https:\/\/doi.org\/10.14218\/JCTH.2016.00054","journal-title":"J Clin Transl Hepatol"},{"issue":"14","key":"3621_CR17","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1128\/JVI.00629-11","volume":"85","author":"KD Ibarra","year":"2011","unstructured":"Ibarra KD, Jain MK, Pfeiffer JK (2011) Host-based ribavirin resistance influences hepatitis C virus replication and treatment response. J Virol 85(14):7273\u20137283. https:\/\/doi.org\/10.1128\/JVI.00629-11","journal-title":"J Virol"},{"issue":"3","key":"3621_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.gastro.2016.11.002","volume":"152","author":"S Elmasry","year":"2017","unstructured":"Elmasry S, Wadhwa S, Bang BR, Cook L, Chopra S, Kanel G et al (2017) Detection of occult hepatitis C virus infection in patients who achieved a sustained virologic response to direct-acting antiviral agents for recurrent infection after liver transplantation. Gastroenterology 152(3):550\u20133.e8. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.002","journal-title":"Gastroenterology"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03621-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:14:19Z","timestamp":1704816859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03621-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["3621"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03621-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"12 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the medical ethics committee in our hospital (IRB NO: 0304965). This research was conducted in accordance with the ethical guidelines of the Declaration of Helsinki and informed consent was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}